Overcoming Barriers for siRNA Therapeutics: From Bench to Bedside
The RNA interference (RNAi) pathway possesses immense potential in silencing any gene in human cells. Small interfering RNA (siRNA) can efficiently trigger RNAi silencing of specific genes. FDA Approval of siRNA therapeutics in recent years garnered a new hope in siRNA therapeutics. However, their t...
Saved in:
Main Authors: | Muhammad Imran Sajid (Author), Muhammad Moazzam (Author), Shun Kato (Author), Kayley Yeseom Cho (Author), Rakesh Kumar Tiwari (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Design, Synthesis, and Evaluation of Oleyl-WRH Peptides for siRNA Delivery
by: Mrigank Shekhar Rai, et al.
Published: (2024) -
siRNA Therapeutics: From Bench Lab. to Clinics
by: Cristina Romero-López, et al.
Published: (2024) -
Cyclic Peptide-Gadolinium Nanocomplexes as siRNA Delivery Tools
by: Amir Nasrolahi Shirazi, et al.
Published: (2021) -
Oleyl Conjugated Histidine-Arginine Cell-Penetrating Peptides as Promising Agents for siRNA Delivery
by: Muhammad Imran Sajid, et al.
Published: (2022) -
Biotechnological Evolution of siRNA Molecules: From Bench Tool to the Refined Drug
by: Danielle de Brito e Cunha, et al.
Published: (2022)